drugset / Trial / NCT02381236
G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancer
NaSingle-groupOpen-labelTreatment
Summary
A single-arm, open-label Phase II clinical trial to evaluate the effect of G-202 on the perfusion and volume of the prostate using non-invasive multiparametric prostate magnetic resonance imaging (mpMRI).
Timeline
- Start
- 2016-02
- Primary completion
- 2016-12
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mipsagargin | Other / unclassified | — | Intravenous |